The World Health Organization’s (WHO) new recommendation for the extended use of triple drug antiretroviral prophylaxis for mother and infant is highly cost-effective compared to the current short-course two drug therapy for the prevention of mother-to-child transmission (PMTCT) in Nigeria.

Read full article here.